Skin Spectrum Weekly

Essential update: CaSMO guidelines for CAEs in skin of colour patients

New phenotype-specific recommendations address the unique diagnostic and therapeutic challenges of cutaneous adverse events in diverse patient…

17 hrs ago • John Evans

A new approach for dyschromia in skin of colour: 2-MNG shows promise

New study finds a 2-MNG serum and sunscreen regimen effectively improves facial dyschromia, texture, and quality of life for SoC patients (Issue #525…

Feb 2 • John Evans

4

1

January 2026

Rethinking prevention: Study shows cultural outreach cuts skin cancer disparities

Culturally tailored, in-person education raised skin cancer awareness and confidence in self-exams among underserved Spanish- and Punjabi-speaking…

Jan 26 • John Evans

4

3

1

Seeing the full picture: Culture, race, and ethnicity in pediatric dermatology

Assuring best skin outcomes for children relies on knowing variations in presentation, frequency, and cultural perception (Issue #523, 1,800 words, 9…

Jan 19 • John Evans

Beyond male pattern baldness: The overlooked signs of scarring alopecia in male patients of colour

In men with SoC, scarring hair loss is frequently mislabeled as androgenetic alopecia—delaying treatment and risking permanent damage (Issue #522, 1,600…

Jan 12 • John Evans

1

1

December 2025

Triple-combination CAB gel effective, well-tolerated in all age groups

Today's report also covers acne scarring, reducing sebum production, dry eye symptoms, and more (1,800 words, 7 minutes, 30 seconds)

Dec 19, 2025 • Jeremy Visser

1

Two decades of progress: Assessing the state of skin of colour dermatology

Charting 20 years of advances in diagnosing and treating skin diseases in diverse populations—from inflammatory conditions to to cosmetic interventions…

Dec 15, 2025 • John Evans

Reconsidering IL-23 inhibitors in axial psoriatic arthritis

Today's report also covers tildrakiumab dosing, IL-23 inhibitors, and more (1,600 words, 7 minutes, 10 seconds)

Dec 10, 2025 • Jeremy Visser

Building better trials: How inclusive design can close dermatology's evidence gap

Dr. Geeta Yadav addresses the stark lack of diversity in derm research, arguing that representative trials are not only an ethical imperative but a…

Dec 8, 2025 • John Evans

1

A diagnostic blind spot? Improving early HS detection in darker skin

Harder to detect erythema often leads to delayed diagnosis and more severe disease. Learn how a proactive, interdisciplinary approach can improve…

Dec 1, 2025 • John Evans

1

November 2025

Rethinking pigmentation: It’s not just about more melanin, it’s about slower degradation

Slower decay of pigment-containing organelles, not number or quantity of melanin, may be the primary driver of skin colour (Issue #518, 1,500 words, 7…

Nov 24, 2025 • John Evans

Tildrakizumab treatment patterns in moderate-to-severe plaque psoriasis: Canadian real-world evidence

Today's report also covers novel oral inhibitors, real-world switching patterns, and more (1,400 words, 6 minutes, 30 seconds)

Nov 21, 2025 • Jeremy Visser

1